Amor B, Dougados M, Listrat V et al.: Are classification criteria for spondylarthropathy useful as diagnostic criteria? Rev Rheum Engl Ed; 62:10-15 (1995)
Baraliakos X, Landewe R, Hermann KG et al.: Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging. Ann Rheum Dis; 64(5):730-4 (2005); Epub (2004)
Baraliakos X, Sieper J, Brandt J et al.: Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 years of treatment with the anti-tumour necrosis factor agent infliximab.
Rheumatology, Oxford; 44(12):1525-30. Epub (2005) A
Baraliakos X, Rudwaleit M, Sieper J et al.: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab. Arthritis Res Ther.; 7(3):R439-44. Epub (2005) B
Bechterew, W. von: Steifigkeit der Wirbelsäule und ihre Verkrümmung als besondere Krankheitsform. Neurol. Zentralbl.; 12:426-434 (1893)
Bellamy N, Park W, Rooney PJ: What do we know about the sacroiliac joint? Semin Arthr Rheum.; 12:282-313 (1983)
Bennet PH, Wood PHN: Population studies of the rheumatic diseases. Amsterdam:
Excerpta Media Foundation; 456-457 (1968)
Bollow M, Braun J, Hamm B et al.: Early sacroiliitis in patients with spondylo-arthropathy: evaluation with dynamic gladolinium-enhanced MR imaging. Radiology;
194(2):529-536 (1995)
Bollow M: Moderne bildgebende Diagnostik bei ankylosierender Spondylitis, Ankylosierende Spondylitis, Hrsg.: K.L. Schmidt, Novartis Pharma Verlag; 90429 Nürnberg:81 (2001) A
Bollow M: Moderne bildgebende Diagnostik bei ankylosierender Spondylitis, Ankylosierende Spondylitis, Hrsg.: K.L. Schmidt, Novartis Pharma Verlag, 90429 Nürnberg:92 (2001) B
Brandt J, Bollow M, Rudwaleit M et al.: Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy. Rheumatology (Oxford);
38:831-836 (1999)
Braun J, Bollow M, Sieper J et al.: Use of magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum.; 37:10391045 (1994)
Literaturverzeichnis
83
Braun J, Bollow M, Sieper J et al.: Prevalence of spondylathropathies in HLA B27 positive and -negative blood donors. Arthritis Rheum.; 41:58-67 (1998)
Braun J, Baraliakos X, Golder W et al.: Magnetic Resonance Imaging Examinations of the Spine in patients with Ankylosing Spondylitis, before and after successful therapy with infliximab. Arthritis and Rheumatism; 48(4):1126-36 (2003) A
Braun J, Brandt J, Golder W, et al.: Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of three-month, randomized, placebo-controlled trial. Arthritis Rheum.; 48(8):2224-33 (2003) B Braun J, Alten R et al.: Efficacy of sulfasalazine in undifferentiated spondyloarthritis and early ankylosing spondylitis: A multicenter randomized controlled trial. Ann Rheum Dis.;
63 Suppl.1:413 (2004)
Braun J, Zochling J, Baraliakos X et al.: Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis.; 65(9):1147-53 (2006)
Brewerton DA, Hart FD, Nichols A. et al.: Ankylosing spondylitis and HLA B27;
Lancet:904-907 (1973)
Calin A, Porta J, Fries JF et al.: Clinical history as a screening test for ankylosing spondylitis. JAMA; 237:2613-2614 (1977)
Calin A, Brophy S, Mackay K et al: Ankylosing Spondylitis: For given radiological involvement, who suffers more – men or women? Poster presentation at the british Society of Rheumatology Heberdon Round Meeting, Belfast (1997)
Chen J, Liu C, Lin J: Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev; 3:CD004524 (2004)
Connor B: De stupendo ossium coalitu dissertatio medico physica. Oxford (1693)
Dihlmann W: Current radiodiagnostic concept of ankylosing spondylitis. Skeletal Radiol.; 4:179-188 (1979)
Dougados M, van der Linden S, Juhlin R et al.: The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum.; 34 (10):1218-30 (1991)
Dougados M, Gueguen A, Nakache JP et al.: Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol.; 26(4):971-4 (1999)
Dwyer AJ, Frank JA, Sank VJ et al.: Short-TI-inversion-recovery pulse sequence:
analysis and initial experience in cancer imaging. Radiology; 168:827-36 (1988)
84
FDA: Guidance for Industry. Guidelines for the Clinical Evaluation of Anti-Inflammatory and Antirheumatic Drugs (Adults and Children). US Department of Human and Health Services: 39 (1977, revised 1988)
(www.fda.gov/cder/guidance/old048fn.pdf). Appendix 5 of the FDA.
Feldtkeller E, Khan MA, van der Heijde D et al.: Age at disease onset and delayed diagnosis of spondylarthropathies. Z Rheumatol.; 58(1):21-30 (1999)
Fleckenstein JL, Archer BT, Barker BA et al.: fast short-tau inversion-recovery MR imaging. Radiology 179 (2):199-504 (1991)
Garrett S, Jenkinson T, Kennedy LG et al.: A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index.
J Rheumatol.; 21:2286-2291 (1994)
Haibel H, Brandt HC, Song IH et al.: No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial. Epub ahead of print (2006), Ann Rheum Dis.; 66 (3):419-21 (2007)
Karberg K: Veränderungen des Knochens bei Spondylitis ankylosans – eine detaillierte Analyse von Knochendichte und Knochenneubildung bei Patienten in verschiedenen Krankheitsstadien; Dissertation:53 (2004)
Lange U, Berliner M, Weidner W et al.: Ankylosing spondylitis and urogenital infection:
diagnosis of urogenital infection and correlation with rheumatologic findings.
Z Rheumatol.; 55 (4):249-55 (1996)
Lipsky E, Gromnica-Ihle E: Rheumatoide Arthritis, Harrisons Innere Medizin; 2:21111 (2001)
Lukas C, Braun J, van der Heijde D et al.: Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment.
J Rheumatol.; 34 (4):862-70 (2007)
Mau W, Meran JG, Zeidler H: Concept and criteria of spondylarthritis, Med Wochenschr.; 140 (12):334-8 (1990)
Mau W, Zeidler H, Mau R et al.: Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of 10-year followup. J. Rheumatol.; 15: 1109-1114 (1998)
Puhakka KB, Jurik AG, Schiottz-Christensen B et al.: MRI abnormalities of sacroiliac joints in early spondylarthropathy: a 1-year follow-up study. Scand J Rheumatol.;
33(5):332-338 (2004)
Rudwaleit M, Listing J et al.: Disease activity, severity and function in patients with early ancylosing spondylitis and undifferentiated axial spondyloarthritis. Arthritis Rheum.;
48(Suppl.):174 (2003)
Literaturverzeichnis
85
Rudwaleit M, Sieper J: Diagnosis and early diagnosis of Ankylosing Spondylitis, Z Rheumatol.; 63(3):193-202 (2004) A
Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J, How to diagnose axial spondyloarthritis early, Ann Rheum Dis.; 63(5):535-43 (2004) B
Rudwaleit M, Listing J, Brandt J et al.: Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis.;
63(6):665-70. Epub (2004) C
Rudwaleit M, Sieper J: Early diagnosis of spondyloarthritis with special attention to the axial forms, Z Rheumatol.; 64(8):524-30 (2005)
Rudwaleit M, Metter A, Listing J et al.: Inflammatory back pain in ankylosing spondylitis:
a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum.; 54(2):569-78 (2006)
Rudwaleit M, Schwarzlose S, Hilgert E et al.: Role of Magnetic Resonance Imaging (MRI) in predicting a Major Clinical Response to Anti-TNF-Treatment in Ankylosing Spondylitis. Ann Rheum Dis. (Epub ahead of print) (2007)
Schattenkirchner M, Krüger K: Natural course and prognosis of HLA B27-positive oligo-arthritis. Clin. Rheumatol.; 6 Suppl.:83-86 (1987)
Sheehan NJ, Slavin BM, Donovan MP et al.: Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins or protease inhibitors in ankylosing spondylitis. Br J Rheumatol.; 25(2): 171-4 (1986)
Sieper J, Braun J: Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum.; 38 (11): 1547-54 (1995)
Sieper J, Braun J.: Epidemiologie und Klinik der ankylosierenden Spondylitis.
Ankylosierende Spondylitis; Hrsg.: K.L. Schmidt:142 (2001)
Song IH, Haibel H, Hilgert E, Sieper J, Rudwaleit M: Validierung des spinalen pain score (SpiPS) als ein Instrument des Rheumatologen zur Erfassung der Krankheits-aktivität bei Ankylosierender Spondylitis. Z Rheumatol.; 65 Suppl. 1:S6 (2006) A (Vortrag FV1-6, DGRh)
Song IH, Haibel H, Hilgert E, Sieper J, Rudwaleit M: Validation of the spinal pain score (SpiPS) as an instrument performed by the rheumatologist to assess disease activity in ankylosing spondylitis. Arthritis Rheum.; 54 (Supplement): S474 (2006) B (Poster Nr.
1124, ACR)
Song IH, Haibel H, Hilgert E et al.: Role of the physical examination of the spine in the assessment of disease activity in ankylosing spondylitis. Ann Rheum Dis.; 66 (Suppl II):
63 (EULAR, Vortrag OP0042) (2007)
86
Sporenberg A, van der Heijde D et al.: Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
J Rheumatol.; 26(4):980-984 (1999)
Sporenberg A, van Tubergen A, Landewe R et al.: Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford); 44(6):789-95 Epub (2005)
Vahlensieck M, Seelos K, et al.: Magnetresonanztomographie mit schneller STIR-Technik: Optimierung und Vergleich mit anderen Sequenzen an einem 0,5 Tesla-System. Fortschr. Röntgenstr.: 159:288-294 (1993)
Van Denderen JC, van der Paardt et al.: Double-blind, randomised, placebo-controlled study of leflunomide in the treatment of active ankylosing spondylitis. Ann Rheum Dis;
63 Suppl.1:197 (2004)
Van der Heijde D, Landewe RB, Hermann KG et al.: Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7. J Rheumatol.;
32(10):2042-7 (2005)
Van der Heijde D, Kay-Geert H, Rudwaleit M et al.: Is there a preferred method for scoring activity of the spine by Magnetic Resonance Imaging an Ankylosing Spondylitis? Discussion at OMERACT 8. J Rheumatol; in press (2006)
Van der Linden S, Valkenburg HA, Cats A et al.: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum.; 27 (4):361-368 (1984)
Weidner W, Schiefer H-G, Schmidt KL: Urogenitale Infektionen bei seronegativer
„reaktiver“ Arthritis und ankylosierender Spondylitis. Akt. Rheumatol.; 7:82-85 (1982)
Anhang
87